Silo Pharma Stock Price Prediction
| SILO Stock | USD 1.83 0.01 0.54% |
Oversold Vs Overbought
81
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Silo Pharma based on different types of headlines from major news networks to social media. Using Silo Pharma hype-based prediction, you can estimate the value of Silo Pharma from the perspective of Silo Pharma response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Silo Pharma. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Silo Pharma to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Silo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Silo Pharma after-hype prediction price | USD 1.83 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Silo |
Silo Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of Silo Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Silo Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Silo Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Silo Pharma Estimiated After-Hype Price Volatility
In the context of predicting Silo Pharma's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Silo Pharma's historical news coverage. Silo Pharma's after-hype downside and upside margins for the prediction period are 0.09 and 11.03, respectively. We have considered Silo Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Silo Pharma is abnormally volatile at this time. Analysis and calculation of next after-hype price of Silo Pharma is based on 3 months time horizon.
Silo Pharma OTC Stock Price Prediction Analysis
Have you ever been surprised when a price of a OTC Stock such as Silo Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Silo Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Silo Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.26 | 9.20 | 0.00 | 0.02 | 0 Events / Month | 2 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.83 | 1.83 | 0.00 |
|
Silo Pharma Hype Timeline
Silo Pharma is at this time traded for 1.83. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.02. Silo is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is at this time at 1.26%. %. The volatility of related hype on Silo Pharma is about 72285.71%, with the expected price after the next announcement by competition of 1.81. The company has price-to-book ratio of 0.93. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Silo Pharma has Price/Earnings (P/E) ratio of 118.39. The entity recorded a loss per share of 1.18. The firm had not issued any dividends in recent years. Silo Pharma had 1:50 split on the 15th of September 2022. Given the investment horizon of 90 days the next expected press release will be within a week. Check out Silo Pharma Basic Forecasting Models to cross-verify your projections.Silo Pharma Related Hype Analysis
Having access to credible news sources related to Silo Pharma's direct competition is more important than ever and may enhance your ability to predict Silo Pharma's future price movements. Getting to know how Silo Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Silo Pharma may potentially react to the hype associated with one of its peers.
Silo Pharma Additional Predictive Modules
Most predictive techniques to examine Silo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Silo using various technical indicators. When you analyze Silo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Silo Pharma Predictive Indicators
The successful prediction of Silo Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Silo Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Silo Pharma based on analysis of Silo Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Silo Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Silo Pharma's related companies.
Story Coverage note for Silo Pharma
The number of cover stories for Silo Pharma depends on current market conditions and Silo Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Silo Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Silo Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Silo Pharma Short Properties
Silo Pharma's future price predictability will typically decrease when Silo Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Silo Pharma often depends not only on the future outlook of the potential Silo Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Silo Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.1 M | |
| Cash And Short Term Investments | 7.7 M |
Other Information on Investing in Silo OTC Stock
Silo Pharma financial ratios help investors to determine whether Silo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Silo with respect to the benefits of owning Silo Pharma security.